Patient-Focused Drug Development: Collecting Comprehensive and Representative Input
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 13, 2018
January 26, 2021
abbf838a-9294-4c1b-a0d1-55c963831af5
Related Documents
Patient-Focused Drug Development: Methods to Identify What Is Important to Patients: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders
Guidance DocumentFebruary 25, 2022Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Guidance DocumentJuly 27, 2022Center for Drug Evaluation and Research
Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff
Guidance DocumentNovember 24, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.